[go: up one dir, main page]

IL123551A0 - Tricyclic erythromycin derivatives - Google Patents

Tricyclic erythromycin derivatives

Info

Publication number
IL123551A0
IL123551A0 IL12355196A IL12355196A IL123551A0 IL 123551 A0 IL123551 A0 IL 123551A0 IL 12355196 A IL12355196 A IL 12355196A IL 12355196 A IL12355196 A IL 12355196A IL 123551 A0 IL123551 A0 IL 123551A0
Authority
IL
Israel
Prior art keywords
compounds
erythromycin derivatives
tricyclic
tricyclic erythromycin
antibacterial
Prior art date
Application number
IL12355196A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL123551A0 publication Critical patent/IL123551A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL12355196A 1995-11-08 1996-10-17 Tricyclic erythromycin derivatives IL123551A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55524695A 1995-11-08 1995-11-08
PCT/US1996/016585 WO1997017356A1 (en) 1995-11-08 1996-10-17 Tricyclic erythromycin derivatives

Publications (1)

Publication Number Publication Date
IL123551A0 true IL123551A0 (en) 1998-10-30

Family

ID=24216555

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12355196A IL123551A0 (en) 1995-11-08 1996-10-17 Tricyclic erythromycin derivatives

Country Status (12)

Country Link
EP (1) EP0876388B1 (xx)
JP (1) JP2000500133A (xx)
KR (1) KR19990067492A (xx)
AT (1) ATE259823T1 (xx)
AU (1) AU7447096A (xx)
DE (1) DE69631609T2 (xx)
DK (1) DK0876388T3 (xx)
ES (1) ES2218604T3 (xx)
IL (1) IL123551A0 (xx)
MX (1) MX9803692A (xx)
PT (1) PT876388E (xx)
WO (1) WO1997017356A1 (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
ES2244716T3 (es) * 1996-09-04 2005-12-16 Abbott Laboratories Cetolidos 6-o-sustituidos que tienen actividad antibacteriana.
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
PL337066A1 (en) * 1997-05-29 2000-07-31 Abbott Lab Polycyclic derivatives of erythromycin
ZA987689B (en) * 1997-09-02 1999-02-24 Abbott Lab 3-descladinose 6-O substituted erythromycin derivatives
EP1025114B1 (en) * 1997-09-30 2004-02-25 Abbott Laboratories 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
US6034069A (en) * 1997-09-30 2000-03-07 Abbott Laboratories 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
CO4990972A1 (es) * 1997-10-29 2000-12-26 Abbott Lab Derivados de eritromicina en puente 6,11
US6046171A (en) * 1997-10-29 2000-04-04 Abbott Laboratories 6,11-bridged erythromycin derivatives
US6124269A (en) * 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
PA8461401A1 (es) * 1997-10-29 2000-05-24 Pfizer Prod Inc Derivados de eritromicina triciclicos
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
PT952157E (pt) * 1998-04-24 2003-11-28 Pfizer Prod Inc Derivados 9a, 11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina
US6248719B1 (en) 1998-06-03 2001-06-19 Pfizer Inc Tricyclic 3-keto derivatives of 6-O-methylerthromycin
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
JP2005503416A (ja) 2001-09-17 2005-02-03 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 6−o−カルバメート−11,12−ラクト−ケトライド抗菌剤
HUP0500018A3 (en) 2001-12-05 2009-09-28 Ortho Mcneil Pharm Inc 6-o-acyl ketolide derivatives of erythromycine processes for preparing them and using them as antibacterials
CA2487918A1 (en) * 2002-05-31 2003-12-11 Janssen Pharmaceutica N.V. 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents
ES2331867B1 (es) 2008-07-17 2010-10-27 Entrechem, S.L. Sintesis enzimatica de derivados enantiomericamente enriquecidos de trans-ciclopentano- 1,2-diaminas.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0166096B1 (ko) * 1990-11-28 1999-01-15 우에하라 아키라 6-0-메틸에리쓰로마이신 a 유도체
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
WO1993021200A1 (fr) * 1992-04-22 1993-10-28 Taisho Pharmaceutical Co., Ltd. Derive de 5-o-desosaminylerythronolide a

Also Published As

Publication number Publication date
MX9803692A (es) 1998-09-30
PT876388E (pt) 2004-07-30
EP0876388B1 (en) 2004-02-18
KR19990067492A (ko) 1999-08-25
DE69631609D1 (en) 2004-03-25
ES2218604T3 (es) 2004-11-16
AU7447096A (en) 1997-05-29
DE69631609T2 (de) 2005-01-05
JP2000500133A (ja) 2000-01-11
DK0876388T3 (da) 2004-06-07
EP0876388A1 (en) 1998-11-11
ATE259823T1 (de) 2004-03-15
WO1997017356A1 (en) 1997-05-15

Similar Documents

Publication Publication Date Title
IL123551A0 (en) Tricyclic erythromycin derivatives
CA2263972A1 (en) 6-o-substituted ketolides having antibacterial activity
CA2253338A1 (en) 6-o-substituted erythromycins and method for making them
PT1021456E (pt) Derivados macrociclicos de eritromicinas a e b de anel de 13 membros
UA29435C2 (uk) Похідні 3бета-алкенілпенаму та їх фармацевтично прийнятні солі
CA2219656A1 (en) Antibacterial cephalosporins
AU5290199A (en) Erythromycin derivatives with antibiotic activity
CA2046069A1 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
AU7498494A (en) New bis-naphthalimides for the treatment of cancer
IL126625A0 (en) 6-o-substituted erythromycin compounds and method for making same
CA2380455A1 (en) 9a-azalides with antibacterial activity
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
CA2041240A1 (en) Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
CA2235942A1 (en) Tricyclic erythromycin derivatives
ATE42305T1 (de) Antibiotika, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
IL123386A0 (en) 3-Deoxy-3-descladinose derivatives of erythromycins
BG103985A (en) Multicyclic derivatives of erythromycin
CA2056823A1 (en) Derivatives of 10,11,12,13-Tetrahydrodesmycosin Processes for Preparation, and Use Thereof in Pharmaceuticals
CA2013226A1 (en) Cephalosporin derivatives and processes for their preparation
CA2563965A1 (en) 6-0-substituted ketolides having antibacterial activity
MX9704253A (es) Derivados de 9-0-oxima de eritromicina o dotados con actividad antibiotica.
AU5508399A (en) Erythromycin derivative with antibiotic activity